Nirav Shah to Neoplasms, Second Primary
This is a "connection" page, showing publications Nirav Shah has written about Neoplasms, Second Primary.
Connection Strength
0.241
-
Outcomes of patients with secondary central nervous system lymphoma following CAR T-cell therapy: a multicenter cohort study. J Hematol Oncol. 2023 11 09; 16(1):111.
Score: 0.191
-
Subsequent malignant neoplasms in patients previously treated with anti-CD19 CAR T-cell therapy. Blood Adv. 2024 05 28; 8(10):2327-2331.
Score: 0.050